NasdaqCM - Delayed Quote • USD
Organovo Holdings, Inc. (ONVO)
At close: April 18 at 4:00 PM EDT
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
242.0000
370.0000
1,500.0000
--
Operating Expense
20,011.0000
18,101.0000
12,979.0000
16,826.0000
Operating Income
-19,769.0000
-17,731.0000
-11,479.0000
-16,826.0000
Net Non Operating Interest Income Expense
531.0000
454.0000
8.0000
15.0000
Other Income Expense
155.0000
20.0000
25.0000
-13.0000
Pretax Income
-19,083.0000
-17,257.0000
-11,446.0000
-16,824.0000
Tax Provision
2.0000
2.0000
2.0000
2.0000
Net Income Common Stockholders
-19,085.0000
-17,259.0000
-11,448.0000
-16,826.0000
Diluted NI Available to Com Stockholders
-19,085.0000
-17,259.0000
-11,448.0000
-16,826.0000
Basic EPS
-2.16
-1.98
-1.32
-2.44
Diluted EPS
-2.16
-1.98
-1.32
-2.44
Basic Average Shares
8,816.9720
8,713.0320
8,703.5960
6,902.0000
Diluted Average Shares
8,816.9720
8,713.0320
8,703.5960
6,902.0000
Total Operating Income as Reported
-19,769.0000
-17,731.0000
-11,479.0000
-16,826.0000
Total Expenses
20,011.0000
18,101.0000
12,979.0000
16,826.0000
Net Income from Continuing & Discontinued Operation
-19,085.0000
-17,259.0000
-11,448.0000
-16,826.0000
Normalized Income
-19,207.4500
-17,274.8000
-11,448.0000
-16,807.0000
Interest Income
531.0000
454.0000
8.0000
15.0000
Net Interest Income
531.0000
454.0000
8.0000
15.0000
EBIT
-19,769.0000
-17,731.0000
-11,479.0000
-16,826.0000
EBITDA
-19,501.0000
-17,438.0000
-11,337.0000
-16,785.0000
Reconciled Depreciation
268.0000
293.0000
142.0000
41.0000
Net Income from Continuing Operation Net Minority Interest
-19,085.0000
-17,259.0000
-11,448.0000
-16,826.0000
Total Unusual Items Excluding Goodwill
155.0000
20.0000
--
-19.0000
Total Unusual Items
155.0000
20.0000
--
-19.0000
Normalized EBITDA
-19,656.0000
-17,458.0000
-11,337.0000
-16,766.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
Tax Effect of Unusual Items
32.5500
4.2000
--
--
3/31/2021 - 2/14/2012
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
SNGX Soligenix, Inc.
0.4353
-14.65%
LGVN Longeveron Inc.
2.0100
-3.83%
ELYM Eliem Therapeutics, Inc.
4.1800
-5.64%
ALLR Allarity Therapeutics, Inc.
1.5400
+2.67%
PXMD PaxMedica, Inc.
0.7631
-4.60%
PALI Palisade Bio, Inc.
5.07
-23.18%
RLYB Rallybio Corporation
1.6700
-5.11%
SPRC SciSparc Ltd.
1.2900
-2.27%
ADIL Adial Pharmaceuticals, Inc.
2.1700
-6.47%
CADL Candel Therapeutics, Inc.
5.46
+0.37%